Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021
SANTA CLARA, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Month: October 2021
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the…
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug…
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW)…
Levitee Labs Publishes First Revenue Figures for August 2021
Levitee Labs achieves August 2021 revenues of $893,863 Levitee Clinics & Pharmacies achieves August 2021…
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board’s Second Member SAN DIEGO, Oct. 05,…
TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy
CAMBRIDGE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development…
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
Scopus BioPharma to Present at the LD Micro Main Event
Scopus to present on the recent launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology…
Albireo Recognizes PFIC Awareness Day 2021
BOSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare pediatric…
Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development
Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon System for Both…
Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer
NEW YORK and SCOTTSDALE, Ariz., Oct. 05, 2021 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey…
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
SAN DIEGO, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”),…
Better Choice Announces Participation in Upcoming Investor Conferences in October 2021
NEW YORK, Oct. 05, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (the “Company”…
Outlook Therapeutics to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Outlook Therapeutics senior leadership team to provide a company overview and participate on industry panel…
Salarius Pharmaceuticals to Present at the 2021 BioFuture Conference
HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
Experienced commercial leader brings 20 years of experience in pharma PRINCETON, N.J., Oct. 05, 2021…
Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings
– Clinical update and translational data from SPEARHEAD-1 in patients with synovial sarcoma and MRCLS…
VYNE Therapeutics Announces its China Partner’s Enrollment of First Patient in Phase 3 Study of AMZEEQ® in Patients with Moderate to Severe Acne
BRIDGEWATER, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…